Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Cris
    Junior Member
    • May 2011
    • 3

    #1

    increase in quality over the first 14 in illumina data

    Hi,

    I am new here and I coudn't find the answer in the forun, so here it goes: As far as I know the quality of the sequencing is decreasing by the end of the reads, but in my data I have a increasing quality until the 14th base, than it starts to drop.



    Why is the quality increasing? There is a explanation for this to happen? If you could point me to a reference that explains this would be great.
    Thank you very much!
  • kmcarr
    Senior Member
    • May 2008
    • 1181

    #2
    Discussion of next-gen sequencing related bioinformatics: resources, algorithms, open source efforts, etc

    Comment

    • Vinz
      Member
      • Dec 2010
      • 80

      #3
      Yes, that is normal.
      Why?
      To determine Q values, they analyze some characteristics of the basecalls. With those characteristics they go into a table to make a Q value out of it. This table is derived from training data sets where they know the sequence. Now, for some reason they found out, that it works best, if they use different look up tables depending on the cycle number. That results in the strange picture of increasing Q values at the beginning of the read. Basically, the used look up tables max out at different Qs.
      So far for a biologists explanation of whats going on...

      Comment

      • Cris
        Junior Member
        • May 2011
        • 3

        #4
        Thank you Vinz!
        Do you have any source or reference that I can go to use on a presentation? This is a question that we are debating with other problems relating to a sequencing.

        Thank you again!

        Comment

        • Vinz
          Member
          • Dec 2010
          • 80

          #5
          Maybe something is mentioned here:
          RTA Training video

          And there is a document called "RTATheoryofOps" which describes lots of theoretical details about phasing, matrix, base calling... I can not find it online anymore. But your Illumina support should be able to give it to you.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
            by SEQadmin2



            CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

            Despite this, “CRISPR helped turn genome editing from a specialized technique into
            ...
            Yesterday, 11:01 AM
          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Yesterday, 02:55 AM
          0 responses
          9 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          12 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-23-2026, 11:41 AM
          0 responses
          12 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-20-2026, 11:10 AM
          0 responses
          24 views
          0 reactions
          Last Post SEQadmin2  
          Working...